PTH and secondary hyperparathyroidism: Also, CAS has been linked to higher levels of parathyroid hormone (PTH) in patients with secondary hyperparathyroidism and renal insufficiency, paving the way for studies evaluating vitamin D supplementation in these patients to prevent CAS progression.